Results 111 to 120 of about 14,200 (285)

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease

open access: yesGut and Liver, 2020
The current goal of inflammatory bowel disease (IBD) treatment is a symptom-free everyday life accompanied by mucosal healing with minimal use of corticosteroids.
Hiroshi Nakase
doaj   +1 more source

How can you help prevent a recurrence of diverticulitis? [PDF]

open access: yes, 2009
A high-fiber diet is often prescribed after recovery from acute diverticulitis, based on extrapolation from epidemiologic data showing an association between low-fiber diets and diverticulosis (strength of recommendation [SOR]: C, expert opinion).
Jamieson, Barbara, Weisberger, Lise
core  

A novel pH–enzyme-dependent mesalamine colon-specific delivery system

open access: yesDrug Design, Development and Therapy, 2016
Lei Jin, Yi-cun Ding, Yu Zhang, Xiao-qing Xu, Qin Cao Department of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China Abstract: The aim of the present study was to ...
Jin L, Ding Y, Zhang Y, Xu X, Cao Q
doaj  

Not Your Typical Ulcerative Colitis Patient [PDF]

open access: yesModern Medicine
Background: Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD.
Teodora SPATARU   +3 more
doaj   +1 more source

A Rare Presentation of Crohn's Disease [PDF]

open access: yes, 2008
Free peritoneal perforation is a rare complication of Crohn's disease with a report of only 100 cases in the literature. It needs an emergency exploration and an unaware general surgeon is confounded in intraoperative decision-making.
Bhat, Sriram M   +4 more
core   +1 more source

A case of ulcerative colitis presenting as pyoderma gangrenosum and lung nodule [PDF]

open access: yes, 2014
Pyoderma gangrenosum is a phenomenon of cutaneous ulceration where etiology is not well understood. About half of the cases have an associated extracutanoeus manifestation or associated systemic diseases.
Subhash Chandra, Xin Li
core   +1 more source

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine

open access: yesDrug Design, Development and Therapy, 2011
Lilliana Oliveira, Russell D CohenThe Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Chicago, IL, USAAbstract: The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first ...
Lilliana Oliveira, Russell D Cohen
doaj  

Pediatric case of mesalazine‐induced interstitial nephritis with literature review [PDF]

open access: yes, 2013
We present the case of a 14‐year‐old boy with ulcerative colitis who was diagnosed with mesalazine‐induced interstitial nephritis ( M‐IIN ). Improvement in renal function occurred with discontinuation of mesalazine and corticosteroid therapy.
Co, Maridine L., Gorospe, Emmanuel C.
core   +1 more source

Oral adjuvant curcumin therapy for attaining clinical remission in ulcerative colitis: A systematic review and meta-analysis of randomized controlled trials [PDF]

open access: yes, 2018
Curcumin has demonstrated anti-inflammatory properties and has been investigated as an adjuvant therapy of ulcerative colitis (UC). The scope of this study was to systematically review and meta-analyze the efficacy of oral curcumin administration as an ...
Asteriou, Eleni   +5 more
core   +1 more source

A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D) [PDF]

open access: yes, 2015
Introduction: Immune activation has been reported in the mucosa of irritable bowel syndrome patients with diarrhoea (IBS-D) and some small studies have suggested that Mesalazine may reduce symptoms.
Abed Zaitoun   +50 more
core   +1 more source

Home - About - Disclaimer - Privacy